CeQur SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CeQur SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10328
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CeQur SA (CeQur) is a medical device company that develops and commercializes insulin delivery systems. The company offers product PAQ, a wearable insulin delivery device, which delivers both basal and bolus doses. Its PAQ product consist two components such as insulin reservoir and messenger. CeQur enables people to easily experience the benefits of intensive insulin therapy and thereby remaining free from the burdens of daily insulin injections. The company’s insulin delivery systems are used in the treatment of type2 diabetes. It has operations in Switzerland and the US. CeQur is headquartered in Lucerne, Switzerland.

CeQur SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CeQur SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CeQur SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CeQur SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CeQur SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
CeQur SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CeQur SA, Medical Equipment, Deal Details 10
Asset Purchase 10
CeQur Acquires Assets from Calibra Medical 10
Venture Financing 11
CeQur Raises USD100 Million in Series C Financing 11
CeQur Raises US$27 Million In Series B Financing 13
CeQur SA – Key Competitors 15
CeQur SA – Key Employees 16
CeQur SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CeQur SA, Medical Equipment, Key Facts 2
CeQur SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CeQur SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CeQur SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CeQur SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CeQur SA, Deals By Market, 2012 to YTD 2018 8
CeQur SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CeQur Acquires Assets from Calibra Medical 10
CeQur Raises USD100 Million in Series C Financing 11
CeQur Raises US$27 Million In Series B Financing 13
CeQur SA, Key Competitors 15
CeQur SA, Key Employees 16
CeQur SA, Subsidiaries 17

List of Figures
CeQur SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CeQur SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CeQur SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CeQur SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CeQur SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CeQur SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
CeQur SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CeQur SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[CeQur SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Karolinska Development AB (KDEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • NeoGenomics Inc (NEO)-医療機器分野:企業M&A・提携分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • salesforce.com, inc.:企業の戦略・SWOT・財務情報
    salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report Summary salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Panariagroup Industrie Ceramiche SpA:企業の戦略・SWOT・財務情報
    Panariagroup Industrie Ceramiche SpA - Strategy, SWOT and Corporate Finance Report Summary Panariagroup Industrie Ceramiche SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Westpac Banking Corporation:企業の戦略・SWOT・財務情報
    Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Reply S.p.A. (REY):企業の財務・戦略的SWOT分析
    Reply S.p.A. (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Advance Synergy Berhad:企業の戦略・SWOT・財務情報
    Advance Synergy Berhad - Strategy, SWOT and Corporate Finance Report Summary Advance Synergy Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Celina Insurance Group:企業の戦略・SWOT・財務情報
    Celina Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Celina Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Inception Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Inception Sciences Inc (Inception Sciences) is a pharmaceutical company that offers drug discovery incubators. The company develops new companies in partnership with academic researchers and biopharmaceutical companies. It develops drugs for various indications such as fibrotic diseases, onc …
  • Nuevolution AS-製薬・医療分野:企業M&A・提携分析
    Summary Nuevolution A/S (Nuevolution), a subsidiary of Nuevolution AB, is a biopharmaceutical company that develops treatments for cancer and chronic inflammatory diseases. It focuses on developing drugs for the treatment of chronic inflammatory diseases such as rheumatoid arthritis, psoriasis; onco …
  • Santhera Pharmaceuticals Holding AG:企業のM&A・事業提携・投資動向
    Santhera Pharmaceuticals Holding AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Santhera Pharmaceuticals Holding AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Hensel Phelps Construction Co:企業の戦略的SWOT分析
    Hensel Phelps Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ardent Health Services:企業の戦略・SWOT・財務分析
    Ardent Health Services - Strategy, SWOT and Corporate Finance Report Summary Ardent Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TVEL Fuel Company:企業の戦略的SWOT分析
    TVEL Fuel Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kwang Dong Pharmaceutical Co Ltd (009290):製薬・医療:M&Aディール及び事業提携情報
    Summary Kwang Dong Pharmaceutical Co Ltd (Kwang Dong) is a drug manufacturer that develops, manufactures and supplies pharmaceuticals, health drinks and supplements. The company’s pharmaceutical products comprise OTC drugs, ETC drugs, general supplements, OTC drinks, consumer drinks, functional drin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆